- No file added yet -

Tofacitinib in the Treatment of Moderate-to-Severe Rheumatoid Arthritis in China: A Cost-Effectiveness Analysis Based a Mapping Algorithm Derived from a Chinese Population

media

posted on 2021-04-07, 09:02 authored by Adis journalson behalf of, Tan Chongqing, Li Sini, Yi Lidan, Zeng Xiaohui, Peng Liubao, Qin Shuxia, Wang Liting, Wan Xiaomin

Article full text

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).